menu
    • menu

    Company profile for Open Orphan

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and resp...
    Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and respiratory therapeutics, all particularly relevant and topical in the environment of heightened awareness in 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Open OrphanIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    18 Fitzwilliam Place, Dublin 2, D02 HH29
    Telephone
    Telephone
    +353 1 6440007
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.openorphan.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/open-orphan/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/openorphan

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Open Orphan signs £10.4 million contract with global pharma client
    Open Orphan signs £10.4 million contract with global pharma client

    23 Aug 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/735248/open-orphan-signs-104-million-contract-global-pharma-client

    PHARMAFILE
    23 Aug 2022
    Share Share
    Open Orphan to commence influenza human challenge study
    Open Orphan to commence influenza human challenge study

    05 Aug 2022

    // John Pinching PHARMA TIMES

    https://www.pharmatimes.com/news/open_orphan_to_commence_influenza_human_challenge_study_1453010

    John Pinching PHARMA TIMES
    05 Aug 2022
    Share Share
    Open Orphan lands £7.3mln influenza human challenge study
    Open Orphan lands £7.3mln influenza human challenge study

    19 May 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/645329/open-orphan-lands-73mln-influenza-human-challenge-study

    PHARMAFILE
    19 May 2022
    Share Share
    Open Orphan to begin first-ever COVID-19 challenge trial
    Open Orphan to begin first-ever COVID-19 challenge trial

    06 May 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/632901/open-orphan-begin-first-ever-covid-19-challenge-trial

    PHARMAFILE
    06 May 2022
    Share Share
    Open Orphan to conduct first-ever COVID-19 human challenge trial
    Open Orphan to conduct first-ever COVID-19 human challenge trial

    22 Oct 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/592373/open-orphan-conduct-first-ever-covid-19-human-challenge-trial

    PHARMAFILE
    22 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search